The FDA has granted Breakthrough Therapy designation to BPL-003 (mebufotenin benzoate) nasal spray for adults with treatment-resistant depression.

GFR is key marker of kidney function; IgAN is progressive autoimmune kidney disease that leads to kidney failure in many patients 1-3 Fabhalta is first and only approved complement inhibitor for ...

This small SUV could be absolutely huge for Acura. Just as the Integra four-door welcomes new car buyers to the luxury brand, ...

Last year Radxa introduced a mini-ITX motherboard called the Orion O6 that has a 12-core processor featuring high-performance Arm-based CPU cores and an NPU that delivers up to 30 TOPS of AI ...